BlackRock, Inc. 13D and 13G filings for Twist Bioscience Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | TWIST BIOSCIENCE CORP COM TWST | BlackRock Inc. BLK | 4,927,750 8.300% | -1,018,595 (-17.13%) | Filing |
| 2024-01-24 5:23 pm Sale | 2023-12-31 | 13G | TWIST BIOSCIENCE CORP COM TWST | BlackRock Inc. BLK | 5,946,345 10.300% | -266,568 (-4.29%) | Filing |
| 2023-04-06 09:29 am Purchase | 2023-03-31 | 13G | TWIST BIOSCIENCE CORP COM TWST | BlackRock Inc. BLK | 6,212,913 10.900% | 725,733 (+13.23%) | Filing |
| 2023-01-24 1:56 pm Purchase | 2022-12-31 | 13G | TWIST BIOSCIENCE CORP COM TWST | BlackRock Inc. BLK | 5,487,180 9.700% | 1,153,278 (+26.61%) | Filing |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | TWIST BIOSCIENCE CORP COM TWST | BlackRock Inc. BLK | 4,333,902 8.700% | 834,898 (+23.86%) | Filing |